Volanakis Emmanuel
Last active: 3/7/2018


None provided


The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Epigenetic regulation of the Ink4a-Arf (Cdkn2a) tumor suppressor locus in the initiation and progression of Notch1-driven T cell acute lymphoblastic leukemia. Volanakis EJ, Boothby MR, Sherr CJ (2013) Exp Hematol 41(4): 377-86
    › Primary publication · 23178376 (PubMed) · PMC3860824 (PubMed Central)
  2. Vital roles of mTOR complex 2 in Notch-driven thymocyte differentiation and leukemia. Lee K, Nam KT, Cho SH, Gudapati P, Hwang Y, Park DS, Potter R, Chen J, Volanakis E, Boothby M (2012) J Exp Med 209(4): 713-28
    › Primary publication · 22473959 (PubMed) · PMC3328370 (PubMed Central)
  3. Functional interactions between Lmo2, the Arf tumor suppressor, and Notch1 in murine T-cell malignancies. Treanor LM, Volanakis EJ, Zhou S, Lu T, Sherr CJ, Sorrentino BP (2011) Blood 117(20): 5453-62
    › Primary publication · 21427293 (PubMed) · PMC3109717 (PubMed Central)
  4. Developmental strategies for evasion of Arf tumor suppression. Volanakis EJ, Sherr CJ (2010) Cell Cycle 9(1): 14-5
    › Primary publication · 20009580 (PubMed)
  5. Stage-specific Arf tumor suppression in Notch1-induced T-cell acute lymphoblastic leukemia. Volanakis EJ, Williams RT, Sherr CJ (2009) Blood 114(20): 4451-9
    › Primary publication · 19759355 (PubMed) · PMC2777126 (PubMed Central)
  6. Systematic analysis of the role of CD19 cytoplasmic tyrosines in enhancement of activation in Daudi human B cells: clustering of phospholipase C and Vav and of Grb2 and Sos with different CD19 tyrosines. Brooks SR, Li X, Volanakis EJ, Carter RH (2000) J Immunol 164(6): 3123-31
    › Primary publication · 10706702 (PubMed)